Hemo Organic Board Meeting on Oct 3, 2026 to Consider Fund Raising

Hemo Organic Ltd has announced a Board of Directors meeting scheduled for October 3, 2026. The primary agenda item is to consider and approve a proposal for raising funds through various methods, including equity shares, convertible securities, and warrants. The company may issue these securities for cash or in consideration other than cash, potentially via share swap, preferential allotment, private placement, QIP, rights issue, or further public issue. The meeting will also address any other business with the Chairman's permission. Additionally, the trading window will be closed from September 29, 2026, until 48 hours after the declaration of financial results for the quarter and half-year ended September 2026, in compliance with SEBI regulations on insider trading.